IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer

Abstract Background IGF2BP3 expression is associated with poor prognosis in cancers of multiple tissue origins. However, the precise mechanism of its co-carcinogenic action in bladder cancer is unknown. Methods We aimed to demonstrate the relationship between IGF2BP3 expression and pan-cancer using...

Full description

Bibliographic Details
Main Authors: Wei Huang, Lizhen Zhu, Haoxuan Huang, Yuanyuan Li, Gongxian Wang, Cheng Zhang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-022-10353-5
_version_ 1811171711410765824
author Wei Huang
Lizhen Zhu
Haoxuan Huang
Yuanyuan Li
Gongxian Wang
Cheng Zhang
author_facet Wei Huang
Lizhen Zhu
Haoxuan Huang
Yuanyuan Li
Gongxian Wang
Cheng Zhang
author_sort Wei Huang
collection DOAJ
description Abstract Background IGF2BP3 expression is associated with poor prognosis in cancers of multiple tissue origins. However, the precise mechanism of its co-carcinogenic action in bladder cancer is unknown. Methods We aimed to demonstrate the relationship between IGF2BP3 expression and pan-cancer using The Cancer Genome Atlas (TCGA) database. We next validated IGF2BP3 expression in the Gene Expression Omnibus (GEO) database (GSE3167). Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic values of IGF2BP3. Cox and logistic regression were used to explore the factors affecting the prognosis. Protein–protein interactions (PPIs) network was constructed by STRING. Enrichment analyses were performed to infer involved pathways and functional categories of IGF2BP3 using the cluster Profiler package. We applied single-sample gene set enrichment analysis (ssGSEA) algorithm and TIMER database to evaluate the expression level of immune genes. Results Pan-cancer analyses reveal that IGF2BP3 was higher in most cancer types, including bladder cancer, and the same results were found in GSE3167. The area under the ROC curve of IGF2BP3 was 0.736, which indicated that IGF2BP3 may be a potential diagnostic biomarker. High IGF2BP3 expression was associated with poorer overall survival (OS) (P = 0.015). For validation, we collected 95 bladder cancer samples and found that IGF2BP3 expression was higher in bladder cancer tissues than that in non-tumor bladder tissues by immunohistochemistry staining. We found a positive correlation between the expression level of IGF2BP3 and the clinical stage of bladder cancer. Immunocyte infiltration analysis showed that high IGF2BP3 expression was correlated with regulating the infiltration level of immune cell, including neutrophil cells and macrophages. IGF2BP3 promotes migration and invasion of bladder cancer cells, while IGF2BP3 inhibition had the opposite effects. Higher IGF2BP3 expression was closely associated with advanced TNM stage. Conclusion IGF2BP3 overexpression was related to disease progression and poor prognosis, as well as infiltration of immune cells in bladder cancer. IGF2BP3 can be a promising independent prognostic biomarker and potential treatment target for bladder cancer.
first_indexed 2024-04-10T17:18:34Z
format Article
id doaj.art-9ce004819a884329a7d185f99082d5d4
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-10T17:18:34Z
publishDate 2023-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-9ce004819a884329a7d185f99082d5d42023-02-05T12:15:41ZengBMCBMC Cancer1471-24072023-02-0123111810.1186/s12885-022-10353-5IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancerWei Huang0Lizhen Zhu1Haoxuan Huang2Yuanyuan Li3Gongxian Wang4Cheng Zhang5Department of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Oncology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityAbstract Background IGF2BP3 expression is associated with poor prognosis in cancers of multiple tissue origins. However, the precise mechanism of its co-carcinogenic action in bladder cancer is unknown. Methods We aimed to demonstrate the relationship between IGF2BP3 expression and pan-cancer using The Cancer Genome Atlas (TCGA) database. We next validated IGF2BP3 expression in the Gene Expression Omnibus (GEO) database (GSE3167). Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic values of IGF2BP3. Cox and logistic regression were used to explore the factors affecting the prognosis. Protein–protein interactions (PPIs) network was constructed by STRING. Enrichment analyses were performed to infer involved pathways and functional categories of IGF2BP3 using the cluster Profiler package. We applied single-sample gene set enrichment analysis (ssGSEA) algorithm and TIMER database to evaluate the expression level of immune genes. Results Pan-cancer analyses reveal that IGF2BP3 was higher in most cancer types, including bladder cancer, and the same results were found in GSE3167. The area under the ROC curve of IGF2BP3 was 0.736, which indicated that IGF2BP3 may be a potential diagnostic biomarker. High IGF2BP3 expression was associated with poorer overall survival (OS) (P = 0.015). For validation, we collected 95 bladder cancer samples and found that IGF2BP3 expression was higher in bladder cancer tissues than that in non-tumor bladder tissues by immunohistochemistry staining. We found a positive correlation between the expression level of IGF2BP3 and the clinical stage of bladder cancer. Immunocyte infiltration analysis showed that high IGF2BP3 expression was correlated with regulating the infiltration level of immune cell, including neutrophil cells and macrophages. IGF2BP3 promotes migration and invasion of bladder cancer cells, while IGF2BP3 inhibition had the opposite effects. Higher IGF2BP3 expression was closely associated with advanced TNM stage. Conclusion IGF2BP3 overexpression was related to disease progression and poor prognosis, as well as infiltration of immune cells in bladder cancer. IGF2BP3 can be a promising independent prognostic biomarker and potential treatment target for bladder cancer.https://doi.org/10.1186/s12885-022-10353-5IGF2BP3Bladder cancerPDL-1Prognosis marker
spellingShingle Wei Huang
Lizhen Zhu
Haoxuan Huang
Yuanyuan Li
Gongxian Wang
Cheng Zhang
IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
BMC Cancer
IGF2BP3
Bladder cancer
PDL-1
Prognosis marker
title IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
title_full IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
title_fullStr IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
title_full_unstemmed IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
title_short IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
title_sort igf2bp3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
topic IGF2BP3
Bladder cancer
PDL-1
Prognosis marker
url https://doi.org/10.1186/s12885-022-10353-5
work_keys_str_mv AT weihuang igf2bp3overexpressionpredictspoorprognosisandcorrelateswithimmuneinfiltrationinbladdercancer
AT lizhenzhu igf2bp3overexpressionpredictspoorprognosisandcorrelateswithimmuneinfiltrationinbladdercancer
AT haoxuanhuang igf2bp3overexpressionpredictspoorprognosisandcorrelateswithimmuneinfiltrationinbladdercancer
AT yuanyuanli igf2bp3overexpressionpredictspoorprognosisandcorrelateswithimmuneinfiltrationinbladdercancer
AT gongxianwang igf2bp3overexpressionpredictspoorprognosisandcorrelateswithimmuneinfiltrationinbladdercancer
AT chengzhang igf2bp3overexpressionpredictspoorprognosisandcorrelateswithimmuneinfiltrationinbladdercancer